MedTrace Logo

Limus Eluted From A Durable Versus ERodable Stent Coating

NCT00389220 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1707

Last updated 2019-05-07

No results posted yet for this study

Summary

The purpose of this study is to compare the BioMatrix Flex (Biolimus A9-Eluting) stent system with the Cypher SELECT (Sirolimus-Eluting) stent system in a non-inferiority trial.

Conditions

  • Coronary Disease
  • Coronary Stenosis

Interventions

DEVICE

Coronary stent placement

Coronary stent placement

Sponsors & Collaborators

  • Biosensors Europe SA

    lead INDUSTRY

Principal Investigators

  • Stephan Windecker, Prof. · Medizinische Universitätsklinik, Swiss Cardiovacular Center Bern

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2008-05-31
Completion
2012-06-30

Countries

  • Belgium
  • France
  • Germany
  • Netherlands
  • Poland
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00389220 on ClinicalTrials.gov